Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-05 @ 3:14 AM
Study NCT ID:
NCT02152956
Status:
TERMINATED
Last Update Posted:
2024-01-30
First Post:
2014-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)
Sponsor:
MacroGenics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-28
First Submit QC Date:
None
Study First Post Date:
2014-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-05
Results First Submit QC Date:
None
Results First Post Date:
2024-01-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-24
Last Update Post Date:
2024-01-30
Last Update Post Date Type:
ACTUAL